SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-05
👔
PRECISION BIOSCIENCES INC
@DTIL_InsiderForm 4 Filing: Buehler Kevin Acquires (Grant) shares of $DTIL
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
PRECISION BIOSCIENCES INC
Ticker: $DTIL
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-03
Shares: 20,979
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Buehler Kevin, holds the title of Director at PRECISION BIOSCIENCES INC.
On 2026-06-03, the insider transacted 20,979 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Buehler Kevin (Director) was granted $0 of $DTIL
Post-Transaction Position: 20,979 shares
SEC Accession No: 0001628280-26-041037 (CIK: 1792722)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.